Molecular Diagnostics in Cancer Therapeutic Development

Newswise — What:

1.The future of cancer treatment relies heavily on: 2.enhanced detection and classification of tumors;3.accuracy to establish target validation and proof of concept;4.improved patient selection to test therapeutic hypotheses most efficiently;5.accuracy in dose and schedule determination; and6.elucidation of mechanism of drug resistance developing molecular risk models to identify 7.high-risk cohorts.

This multidisciplinary conference will become the most important conference devoted to the latest developments in the integration of molecular diagnostics with cancer drug development. This meeting will offer unprecedented opportunities for the translation of basic science into new individualized therapeutic strategies.

This marks the first time that experts, including basic scientists, translational researchers, physician-scientists, clinical oncologists, cancer survivors, and behavioral researchers from academia, government, industry, and advocacy organizations will all come together to discuss the latest developments in molecular diagnostics.

When:September 12-15, 2006

Where:Hyatt Regency Chicago HotelChicago, Ill.

Highlights include:

1.New Frontiers in Diagnostic Technologies2.Molecular Detection and Monitoring of Cancer using Tumor-derived DNA in Plasma3.Emerging Impact of Novel Preclinical Models4.Individual Determinants of Vaccine Therapy5.Regulatory Integration of Diagnostic Markers and Therapeutic Trials6.Determination of Clinically Effective Dose and Schedule7.Determinants of Patient Prognosis and Tumor Response to Cytotoxic Therapies